Metastatic cancer
According to a study published in Clinical Cancer Research, scientists at Mount Sinai conducting clinical trials of a drug targeting a cancer gene found that it increased metastatic cancer patients’ survival, and was able to work within the brain.
One significant finding of the study, not highlighted by initial trials, was that the drug was able to effectively cross the brain-barrier. Researchers found evidence suggesting the therapy was working against metastatic cancer that spread to the brain.
